Peter P. De Cruz

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 140 publications

Reply.

Reply.

Journal: Gastroenterology

Published: April 18, 2026

Tacrolimus Bridging and Combination Therapy Following Infliximab and JAK Inhibitor Failure in Ulcerative Colitis: A Case Series.

Tacrolimus Bridging and Combination Therapy Following Infliximab and JAK Inhibitor Failure in Ulcerative Colitis: A Case Series.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: April 08, 2026

Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort Study.

Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort Study.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: March 12, 2026

Reply.

Reply.

Journal: Gastroenterology

Published: February 17, 2026

Quality of healthcare delivery in inflammatory bowel disease pregnancy: a scoping review.

Quality of healthcare delivery in inflammatory bowel disease pregnancy: a scoping review.

Journal: Inflammatory bowel diseases

Published: November 25, 2025

Monocyte Distribution Width Differentiates Bacterial Enterocolitis from Acute Severe Ulcerative Colitis in the Emergency Department.

Monocyte Distribution Width Differentiates Bacterial Enterocolitis from Acute Severe Ulcerative Colitis in the Emergency Department.

Journal: Digestive diseases and sciences

Published: November 04, 2025

Impact of BECLIN1 haploinsufficiency on goblet cell function and susceptibility to colitis.

Impact of BECLIN1 haploinsufficiency on goblet cell function and susceptibility to colitis.

Journal: Cell death & disease

Published: November 03, 2025

Implementation of values-based healthcare in inflammatory bowel disease-a review.

Implementation of values-based healthcare in inflammatory bowel disease-a review.

Journal: Journal of Crohn's & colitis

Published: September 19, 2025

Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium.

Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: September 05, 2025

Editorial: Redefining Safety in Post-Liver Transplant IBD-Why Therapeutic Effectiveness Is the Ultimate Shield. Authors' Reply.

Editorial: Redefining Safety in Post-Liver Transplant IBD-Why Therapeutic Effectiveness Is the Ultimate Shield. Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: August 05, 2025

IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, Australia.

IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, Australia.

Journal: Journal of gastroenterology and hepatology

Published: May 29, 2025

BECLIN-1 is essential for the maintenance of gastrointestinal epithelial integrity by regulating endocytic trafficking, F-actin organization, and lysosomal function.

BECLIN-1 is essential for the maintenance of gastrointestinal epithelial integrity by regulating endocytic trafficking, F-actin organization, and lysosomal function.

Journal: Autophagy reports

Published: May 21, 2025

Showing 1-12 of 140

Last Updated: 09/26/2026